59 results on '"Rohatgi, Anand"'
Search Results
2. Novel plasma biomarkers of coronary artery calcium incidence or progression: Insights from the prospective multi-ethnic Dallas Heart Study cohort
3. GlycA, hsCRP differentially associated with MI, ischemic stroke: In the Dallas Heart Study and Multi-Ethnic Study of Atherosclerosis: GlycA, hsCRP Differentially Associated MI, Stroke
4. Soluble Fms-like tyrosine kinase-1 (sFlt-1) is associated with subclinical and clinical atherosclerotic cardiovascular disease: The Dallas Heart Study
5. US population qualifying for aspirin use for primary prevention of cardiovascular disease
6. Association of the serum myeloperoxidase/high-density lipoprotein particle ratio and incident cardiovascular events in a multi-ethnic population: Observations from the Dallas Heart Study
7. US POPULATION QUALIFYING FOR ASPIRIN USE FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE
8. The Relationship of Alcohol Consumption and HDL Metabolism in the Multiethnic Dallas Heart Study.
9. AN HDL PROTEOMIC SCORE INDEPENDENTLY PREDICTS INCIDENT ATHEROSCLEROTIC CARDIOVASCULAR DISEASE.
10. Is there a connection between HDL and atrial fibrillation?
11. Is RCT (Reverse Cholesterol Transport) Ready for an RCT (Randomized Controlled Trial)?
12. Soluble endothelial cell-selective adhesion molecule and incident cardiovascular events in a multiethnic population.
13. Coronary Artery Calcium Improves Risk Classification in Younger Populations.
14. High-Density Lipoprotein Function Measurement in Human Studies: Focus on Cholesterol Efflux Capacity.
15. Coronary Artery Calcification and Family History of Myocardial Infarction in the Dallas Heart Study.
16. Discordant effects of rosiglitazone on novel inflammatory biomarkers.
17. Association of chronic lung disease with treatments and outcomes patients with acute myocardial infarction.
18. Race-specific associations of myeloperoxidase with atherosclerosis in a population-based sample: The Dallas Heart Study
19. The association between peptidoglycan recognition protein-1 and coronary and peripheral atherosclerosis: Observations from the Dallas Heart Study
20. Cholesterol Efflux Capacity as a Therapeutic Target: Rationale and Clinical Implications.
21. HDL Cholesterol: Physiology, Pathophysiology, and Management.
22. Elucidating the Link Between Alcohol and HDL Metabolism in the Multiethnic Dallas Heart Study.
23. Measurement and Application of Incidentally Detected Coronary Calcium: JACC Review Topic of the Week.
24. LIPOPROTEIN(A) AND FAMILY HISTORY OF MYOCARDIAL INFARCTION: INSIGHTS FROM THE DALLAS HEART STUDY.
25. The association between HDL particle concentration and incident metabolic syndrome in the multi-ethnic Dallas Heart Study.
26. Assessing Clinical Utility of Carotid Intima-Media Thickness on the Basis of Reclassification
27. THE RELATIONSHIP BETWEEN DEPRESSED LEFT VENTRICULAR FUNCTION BY CARDIAC MRI AND TRADITIONAL CARDIOVASCULAR RISK FACTORS IN PATIENTS EXPOSED TO ANTHRACYCLINES
28. THE ASSOCIATION BETWEEN 2011 ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR APPROPRIATE USE CRITERIA FOR TRANSTHORACIC ECHOCARDIOGRAPHY AND CLINICAL IMPACT
29. Risk scores versus natriuretic peptides for identifying prevalent stage B heart failure.
30. INTERACTIONS BETWEEN SMOKING, CIRCULATING PULMONARY SURFACTANT PROTEIN-B AND AORTIC ATHEROSCLEROSIS IN THE DALLAS HEART STUDY
31. HAPTOGLOBIN COPY NUMBER VARIANTS DO NOT DIMINISH THE EFFECT OF CSL112 (APOA-I [HUMAN]) ON HDL FUNCTION.
32. Circulating lymphotoxin β receptor and atherosclerosis: Observations from the Dallas Heart Study
33. Lipoprotein(a) and Family History Predict Cardiovascular Disease Risk.
34. Beyond Coronary Calcification, Family History, and C-Reactive Protein: Cholesterol Efflux Capacity and Cardiovascular Risk Prediction.
35. Impaired Renal Function on Cholesterol Efflux Capacity, HDL Particle Number, and Cardiovascular Events.
36. Relation of Black Race Between High Density Lipoprotein Cholesterol Content, High Density Lipoprotein Particles and Coronary Events (from the Dallas Heart Study).
37. CORONARY CALCIUM AND FRAMINGHAM RISK SCORE TRAJECTORIES: INSIGHTS FROM THE DALLAS HEART STUDY.
38. The Relationship of Body Mass and Fat Distribution With Incident Hypertension: Observations From the Dallas Heart Study.
39. ASSOCIATIONS OF VISCERAL AND SUBCUTANEOUS ADIPOSE TISSUE MASS WITH MARKERS OF CARDIOMETABOLIC RISK IN OBESE ADULTS: OBSERVATIONS FROM THE DALLAS HEART STUDY
40. Lifetime risks for cardiovascular disease mortality by cardiorespiratory fitness levels measured at ages 45, 55, and 65 years in men. The Cooper Center Longitudinal Study.
41. Association Between Peptidoglycan Recognition Protein-1 and Incident Atherosclerotic Cardiovascular Disease Events: The Dallas Heart Study.
42. USING READILY AVAILABLE CLINICAL INFORMATION TO IDENTIFY INDIVIDUALS WITH HIGH LIPOPROTEIN A LEVELS: THE DALLAS HEART STUDY.
43. SOLUBLE FMS-LIKE TYROSINE KINASE-1 (SFLT-1) IS ASSOCIATED WITH SUBCLINICAL AND CLINICAL ASCVD: THE DALLAS HEART STUDY.
44. INFLAMMATORY MARKER, GLYCA, OUTPERFORMS HSCRP IN PREDICTING CARDIOVASCULAR EVENTS.
45. INFLUENCE OF POST-IMPLANTATION NON-FATAL ADVERSE EVENTS ON CONDITIONAL SURVIVAL IN PATIENTS WITH DURABLE LEFT VENTRICULAR ASSIST DEVICE SUPPORT FOR DESTINATION THERAPY.
46. NOVEL BIOMARKERS OF CORONARY ARTERY CALCIUM INCIDENCE OR PROGRESSION: INSIGHTS FROM THE DALLAS HEART STUDY.
47. Body Fat Distribution and Incident Cardiovascular Disease in Obese Adults.
48. RACIAL AND ETHNIC DIFFERENCES IN CARDIOVASCULAR BIOMARKERS.
49. ENDOTHELIAL CELL-SELECTIVE ADHESION MOLECULE AND INCIDENT CARDIOVASCULAR EVENTS IN THE DALLAS HEART STUDY.
50. LONG-TERM ASSOCIATION OF LDL CHOLESTEROL WITH CARDIOVASCULAR MORTALITY IN INDIVIDUALS AT LOW 10-YEAR RISK OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: THE COOPER CENTER LONGITUDINAL STUDY.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.